Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

This study is ongoing, but not recruiting participants.

Study NCT00003269 Information provided by National Cancer Institute (NCI)

First Received: November 1, 1999 Last Updated: May 9, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Breast Cancer
Drug/Agent Toxicity by Tissue/Organ
Lung Cancer
Lymphoma
Ovarian Cancer

Additional conditions recognized in this trial

Breast Neoplasms
Lung Neoplasms
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Ovarian Neoplasms

Interventions listed in this trial

sargramostim
amifostine trihydrate
cisplatin
cyclophosphamide
etoposide

Additional drug interventions recognized in this trial

Amifostine
Etoposide phosphate

More general drug interventions related to this trial

Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Radiation-Sensitizing Agents
Therapeutic Uses

Sponsors listed in this trial

Ida M. and Cecil H. Green Cancer Center at Scripps Clinic

Back to top of Main Content